Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts3Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts5The VA Healthcare System, Boston, Massachus.
Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts4Division of General Internal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
JAMA. 2014;312(16):1644-52. doi: 10.1001/jama.2014.13336.
An increasing number of hospitals have converted to for-profit status, prompting concerns that these hospitals will focus on payer mix and profits, avoiding disadvantaged patients and paying less attention to quality of care.
To examine characteristics of US acute care hospitals associated with conversion to for-profit status and changes following conversion.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study conducted among 237 converting hospitals and 631 matched control hospitals. Participants were 1,843,764 Medicare fee-for-service beneficiaries at converting hospitals and 4,828,138 at control hospitals.
Conversion to for-profit status, 2003-2010.
Financial performance measures, quality process measures, mortality rates, Medicare volume, and patient population for the 2 years prior and the 2 years after conversion, excluding the conversion year, assessed using difference-in-difference models.
Hospitals that converted to for-profit status were more often small or medium in size, located in the south, in an urban or suburban location, and were less often teaching institutions. Converting hospitals improved their total margins (ratio of net income to net revenue plus other income) more than controls (2.2% vs 0.4% improvement; difference in differences, 1.8% [ 95% CI, 0.5% to 3.1%]; P = .007). Converting hospitals and controls both improved their process quality metrics (6.0% vs 5.6%; difference in differences, 0.4% [95% CI, -1.1% to 2.0%]; P = .59). Mortality rates did not change at converting hospitals relative to controls for Medicare patients overall (increase of 0.1% vs 0.2%; difference in differences, -0.2% [95% CI, -0.5% to 0.2%], P = .42) or for dual-eligible or disabled patients. There was no change in converting hospitals relative to controls in annual Medicare volume (-111 vs -74 patients; difference in differences, -37 [95% CI, -224 to 150]; P = .70), Disproportionate Share Hospital Index (1.7% vs 0.4%; difference in differences, 1.3% [95% CI, -0.9% to 3.4%], P = .26), the proportion of patients with Medicaid (-0.2% vs 0.4%; difference in differences, -0.6% [95% CI, -2.0% to 0.8%]; P = .38) or the proportion of patients who were black (-0.4% vs -0.1%; difference in differences, -0.3% [95% CI, -1.9% to 1.3%]; P = .72) or Hispanic (0.1% vs -0.1%; difference in differences, 0.2% [95% CI, -0.3% to 0.7%]; P = .50).
Hospital conversion to for-profit status was associated with improvements in financial margins but not associated with differences in quality or mortality rates or with the proportion of poor or minority patients receiving care.
越来越多的医院已经转为营利性医院,这引发了人们的担忧,即这些医院将更加关注支付方组合和利润,避免为弱势患者提供服务,并减少对医疗质量的关注。
研究与美国急症护理医院转为营利性地位相关的特征,以及转为营利性地位后的变化。
设计、设置和参与者:对 237 家正在转换的医院和 631 家匹配的对照医院进行回顾性队列研究。参与者为正在转换医院的 1843764 名 Medicare 按服务收费的受益人和 631 家对照医院的 4828138 名 Medicare 按服务收费的受益人。
2003-2010 年转换为营利性地位。
使用差值法评估转换前 2 年和转换后 2 年(不包括转换年)的财务绩效指标、质量流程指标、死亡率、Medicare 量和患者人群。
与对照组相比,转为营利性地位的医院通常规模较小或中等,位于南部,位于城市或郊区,并且不太可能是教学机构。与对照组相比,转换后的医院总利润率(净利润与净收入加其他收入的比率)提高幅度更大(2.2%比 0.4%的改善;差异为 1.8%[95%CI,0.5%至 3.1%];P=0.007)。转换后的医院和对照组的过程质量指标都有所改善(6.0%比 5.6%;差异为 0.4%[95%CI,-1.1%至 2.0%];P=0.59)。与对照组相比,转换后的医院对 Medicare 患者的总体死亡率没有变化(增加 0.1%比 0.2%;差异为-0.2%[95%CI,-0.5%至 0.2%],P=0.42)或双重资格或残疾患者的死亡率没有变化。与对照组相比,转换后的医院 Medicare 量没有变化(-111 比-74 名患者;差异为-37[95%CI,-224 至 150];P=0.70),不成比例的分担医院指数(1.7%比 0.4%;差异为 1.3%[95%CI,-0.9%至 3.4%],P=0.26), Medicaid 患者的比例(-0.2%比 0.4%;差异为-0.6%[95%CI,-2.0%至 0.8%];P=0.38)或黑人患者的比例(-0.4%比-0.1%;差异为-0.3%[95%CI,-1.9%至 1.3%];P=0.72)或西班牙裔患者的比例(0.1%比-0.1%;差异为 0.2%[95%CI,-0.3%至 0.7%];P=0.50)。
医院转为营利性地位与财务利润率的提高有关,但与质量或死亡率的差异或接受治疗的贫困或少数族裔患者的比例无关。